Literature DB >> 15452267

Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus.

Rakesh Kumar1, Cynthia Torres, Yasuhiro Yamamura, Idia Rodriguez, Melween Martinez, Silvija Staprans, Robert M Donahoe, Edmundo Kraiselburd, Edward B Stephens, Anil Kumar.   

Abstract

Six rhesus macaques were adapted to morphine dependence by injecting three doses of morphine (5 mg/kg of body weight) for a total of 20 weeks. These animals along with six control macaques were infected intravenously with mixture of simian-human immunodeficiency virus KU-1B (SHIV(KU-1B)), SHIV(89.6P), and simian immunodeficiency virus 17E-Fr. Levels of circulating CD4(+) T cells and viral loads in the plasma and the cerebrospinal fluid were monitored in these macaques for a period of 12 weeks. Both morphine and control groups showed precipitous loss of CD4(+) T cells. However this loss was more prominent in the morphine group at week 2 (P = 0.04). Again both morphine and control groups showed comparable peak plasma viral load at week 2, but the viral set points were higher in the morphine group than that in the control group. Likewise, the extent of virus replication in the cerebral compartment was more pronounced in the morphine group. These results provide a definitive evidence for a positive correlation between morphine and levels of viral replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452267      PMCID: PMC521826          DOI: 10.1128/JVI.78.20.11425-11428.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

Review 1.  Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.

Authors:  T Pierson; J McArthur; R F Siliciano
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time.

Authors:  P S Silverstein; G A Mackay; S Mukherjee; Z Li; M Piatak; J D Lifson; O Narayan; A Kumar
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Authors:  R R Amara; F Villinger; J D Altman; S L Lydy; S P O'Neil; S I Staprans; D C Montefiori; Y Xu; J G Herndon; L S Wyatt; M A Candido; N L Kozyr; P L Earl; J M Smith; H L Ma; B D Grimm; M L Hulsey; J Miller; H M McClure; J M McNicholl; B Moss; H L Robinson
Journal:  Science       Date:  2001-04-06       Impact factor: 47.728

4.  Pathogenic and nef-interrupted simian-human immunodeficiency viruses traffic to the macaque CNS and cause astrocytosis early after inoculation.

Authors:  Dinesh K Singh; Coleen McCormick; Erik Pacyniak; Darcy Griffin; David M Pinson; Francis Sun; Nancy E J Berman; Edward B Stephens
Journal:  Virology       Date:  2002-04-25       Impact factor: 3.616

5.  Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).

Authors:  A Kumar; J D Lifson; Z Li; F Jia; S Mukherjee; I Adany; Z Liu; M Piatak; D Sheffer; H M McClure; O Narayan
Journal:  Virology       Date:  2001-01-05       Impact factor: 3.616

6.  Morphine induces gene expression of CCR5 in human CEMx174 lymphocytes.

Authors:  T Miyagi; L F Chuang; R H Doi; M P Carlos; J V Torres; R Y Chuang
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

Review 7.  Injection drug use and human immunodeficiency virus infection.

Authors:  P Alcabes; G Friedland
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

8.  Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.

Authors:  Anil Kumar; Sampa Mukherjee; Jing Shen; Shilpa Buch; Zhuang Li; Istvan Adany; Zhenqian Liu; Wu Zhuge; Michael Piatak; Jeffrey Lifson; Harold McClure; Opendra Narayan
Journal:  Virology       Date:  2002-09-30       Impact factor: 3.616

9.  Morphine promotes simian acquired immunodeficiency syndrome virus replication in monkey peripheral mononuclear cells: induction of CC chemokine receptor 5 expression for virus entry.

Authors:  Shunji Suzuki; Ann J Chuang; Linda F Chuang; Roy H Doi; Ronald Y Chuang
Journal:  J Infect Dis       Date:  2002-05-22       Impact factor: 5.226

10.  A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

Authors:  K A Reimann; J T Li; R Veazey; M Halloran; I W Park; G B Karlsson; J Sodroski; N L Letvin
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more
  52 in total

Review 1.  Cannabinoid neuroimmune modulation of SIV disease.

Authors:  Patricia E Molina; Angela Amedee; Nicole J LeCapitaine; Jovanny Zabaleta; Mahesh Mohan; Peter Winsauer; Curtis Vande Stouwe
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-10       Impact factor: 4.147

Review 2.  HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.

Authors:  Peter S Silverstein; Ankit Shah; James Weemhoff; Santosh Kumar; D P Singh; Anil Kumar
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

3.  SIV Vpr evolution is inversely related to disease progression in a morphine-dependent rhesus macaque model of AIDS.

Authors:  Richard J Noel; Anil Kumar
Journal:  Virology       Date:  2006-10-24       Impact factor: 3.616

Review 4.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

5.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

Review 6.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

7.  HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.

Authors:  Nazira El-Hage; Guanghan Wu; Juan Wang; Jayakrishna Ambati; Pamela E Knapp; Janelle L Reed; Annadora J Bruce-Keller; Kurt F Hauser
Journal:  Glia       Date:  2006-01-15       Impact factor: 7.452

8.  Short communication: Lack of immune response in rapid progressor morphine-dependent and SIV/SHIV-infected rhesus macaques is correlated with downregulation of TH1 cytokines.

Authors:  Vanessa Rivera-Amill; Rakesh Kumar; Richard J Noel; Yashira Garcia; Idia V Rodriguez; Melween Martinez; Carlos A Sariol; Edmundo Kraiselburd; Marcus Iszard; Mridul Mukherji; Santosh Kumar; Luis D Giavedoni; Anil Kumar
Journal:  AIDS Res Hum Retroviruses       Date:  2010-08       Impact factor: 2.205

9.  Chronic SIV and morphine treatment increases heat shock protein 5 expression at the synapse.

Authors:  Gurudutt Pendyala; Palsamy Periyasamy; Shannon Callen; Howard S Fox; Steven J Lisco; Shilpa J Buch
Journal:  J Neurovirol       Date:  2015-06-03       Impact factor: 2.643

Review 10.  Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution.

Authors:  Vanessa Rivera-Amill; Peter S Silverstein; Richard J Noel; Santosh Kumar; Anil Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.